Entering text into the input field will update the search result below

European advisory group backs Sanofi meningitis and flu vaccines

Sep. 18, 2020 8:01 AM ETSanofi (SNY) StockSNYBy: Douglas W. House, SA News Editor
  • The European Medicines Agency's advisory group CHMP has adopted a positive opinion recommending approval of Sanofi's (NASDAQ:SNY) MenQuadfi, a prophylactic vaccine against invasive meningococcal disease caused by Neisseria meningitidis serogroups A, C, W and Y.
  • It has also given a thumbs up to Supemtek, its quadrivalent flu vaccine [two A subtypes (H1N1, H3N2) and two B types].
  • A final decision from the European Commission usually takes ~60 days.
  • Shares up 1% premarket on light volume.

Recommended For You

More Trending News

About SNY Stock

SymbolLast Price% Chg
Market Cap
PE
Yield (TTM)
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
SNY--
Sanofi